Literature DB >> 18577446

Poly(N-vinylacetamide) chains enhance lectin-induced biorecognition through the reduction of nonspecific interactions with nontargets.

Ken-ichiro Hiwatari1, Shinji Sakuma, Kiyoko Iwata, Yoshie Masaoka, Makoto Kataoka, Hiroyuki Tachikawa, Yoshikazu Shoji, Shinji Yamashita.   

Abstract

Lectin-immobilized fluorescent nanospheres were designed with the aim of developing a novel endoscopic imaging agent for the detection of early colorectal cancer. Submicron-sized polystyrene nanospheres with surface poly(N-vinylacetamide) (PNVA) and poly(methacrylic acid) (PMAA) chains encapsulating fluorescein-labeled cholesterol were prepared as a platform of the imaging agent. Peanut agglutinin (PNA) was immobilized on the surface of fluorescent nanospheres through a chemical reaction with PMAA in order to recognize beta-D-galactosyl-(1-3)-N-acetyl-d-galactosamine (Gal-beta(1-3)GalNAc), which is the terminal sugar of the Thomsen-Friedenreich antigen that is specifically expressed on the mucosal side of colorectal cancer cells. The effect of surface structure of nanospheres on the affinity and specificity of immobilized PNA for Gal-beta(1-3)GalNAc was examined. Agglutination of normal and Gal-beta(1-3)GalNAc-expressed erythrocytes in the presence of nanospheres showed that PNA was immobilized actively on the nanosphere surface. Molecular weights of PNVA and PMAA affected the PNA activity most strongly. When the weight-average molecular weight of PNVA was nearly equal to that of PMAA, the affinity of PNA immobilized on the nanosphere surface for Gal-beta(1-3)GalNAc was as strong as that of intact PNA; the specificity for the carbohydrate residue was higher than that of the PNA. Results indicated that PNVA enhanced the specificity of PNA through the reduction of nonspecific interactions between PNA and carbohydrates other than Gal-beta(1-3)GalNAc on the erythrocyte surface without a significant decrease in the affinity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18577446     DOI: 10.1016/j.ejpb.2008.04.027

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  4 in total

1.  Tumor recognition of peanut agglutinin-immobilized fluorescent nanospheres in biopsied human tissues.

Authors:  Hironori Kumagai; Kosuke Yamada; Kanako Nakai; Tokio Kitamura; Kohta Mohri; Masami Ukawa; Takumi Tomono; Takaaki Eguchi; Testuya Yoshizaki; Takumi Fukuchi; Takuya Yoshino; Minoru Matsuura; Etsuo Tobita; Wellington Pham; Hiroshi Nakase; Shinji Sakuma
Journal:  Eur J Pharm Biopharm       Date:  2019-01-09       Impact factor: 5.571

2.  A potential of peanut agglutinin-immobilized fluorescent nanospheres as a safe candidate of diagnostic drugs for colonoscopy.

Authors:  Shinji Sakuma; Makoto Kataoka; Haruki Higashino; Takanori Yano; Yoshie Masaoka; Shinji Yamashita; Ken-Ichiro Hiwatari; Hiroyuki Tachikawa; Ryoji Kimura; Kunio Nakamura; Hironori Kumagai; John C Gore; Wellington Pham
Journal:  Eur J Pharm Sci       Date:  2011-01-07       Impact factor: 4.384

3.  Specificity of lectin-immobilized fluorescent nanospheres for colorectal tumors in a mouse model which better resembles the clinical disease.

Authors:  Tokio Kitamura; Shinji Sakuma; Moe Shimosato; Haruki Higashino; Yoshie Masaoka; Makoto Kataoka; Shinji Yamashita; Ken-Ichiro Hiwatari; Hironori Kumagai; Naoki Morimoto; Seiji Koike; Etsuo Tobita; Robert M Hoffman; John C Gore; Wellington Pham
Journal:  Contrast Media Mol Imaging       Date:  2014-06-27       Impact factor: 3.161

4.  Toxicity studies of coumarin 6-encapsulated polystyrene nanospheres conjugated with peanut agglutinin and poly(N-vinylacetamide) as a colonoscopic imaging agent in rats.

Authors:  Shinji Sakuma; Hironori Kumagai; Moe Shimosato; Tokio Kitamura; Kohta Mohri; Tetsuya Ikejima; Ken-Ichiro Hiwatari; Seiji Koike; Etsuo Tobita; Richard McClure; John C Gore; Wellington Pham
Journal:  Nanomedicine       Date:  2015-02-25       Impact factor: 5.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.